NORCROSS, Ga., Jan. 24 /PRNewswire-FirstCall/ -- Immucor, Inc. , the global leader in providing automated instrument-reagent systems to the blood transfusion industry, today reported the settlement of the charges against its Italian subsidiary related to allegedly-improper payments to an Italian physician. On January 18, 2007, the Italian judge approved a plea bargain agreement under which the subsidiary is required to pay a total of approximately $122,000 in fines, penalties, and restitution to a hospital at which the physician worked.
The related charges against Dr. Gioacchino De Chirico, the Company’s President & CEO, and former president of the subsidiary, have now been sent forward to trial. He indicates he will contest any charges against him. The Company expects the trial and related appeals to continue for an extended period of time.
The Company and Dr. De Chirico are still seeking to settle the related SEC investigation in the near term.
Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments. For more information on Immucor, please visit our website at www.immucor.com.
Immucor, Inc.
CONTACT: Patrick Waddy for Immucor, Inc., +1-770-441-2051
Web site: http://www.immucor.com/
